Navigation Links
Bayer CropScience’s Bee Care Program Promotes Honey Bee Health Awareness Through Key Industry Events
Date:1/7/2014

es and the Crop Protection Industry: Our Common Interests,” during AHPA; and

  • Dissemination of materials and engagement with stakeholders to promote best stewardship practices among growers at the Beltwide Cotton Conferences.
  • Bayer has been actively involved in finding solutions to improve honey bee health for more than 25 years. Its Bee Care Program is committed to initiatives designed to advance bee health research, engagement and discussion and bring Bayer’s extensive experience and knowledge in bee health under one platform. As part of that commitment, Bayer participated in more than 100 events throughout 2013 to help improve bee health awareness – from scientific research symposiums to farm tradeshow demonstrations, including the following activities:

    • Broke ground on a new North American Bee Care Center, a state-of-the-art facility to advance honey bee research, education and collaboration, which opens in 2014 at Bayer’s Research Triangle Park, N.C. headquarters;
    • Opened a new Bee Care Field Research Facility in Clayton, N.C., to support the research apiary and work in tandem with broad honey bee health initiatives;
    • Traveled more than 2,000 miles and interacted with more than 2,300 individuals in its Bee Care Tour, a mobile exhibit which visited six Midwestern universities to foster education and collaboration on bee health;
    • Trained more than 300 employees as Bee Amba
      '/>"/>

    Source: PRWeb
    Copyright©2012 Vocus, Inc.
    All rights reserved

    Page: 1 2 3 4 5

    Related biology technology :

    1. Enter to Win the 2013 Bayer CropScience Cotton Belt Challenge
    2. Bayer CropScience Seeks Entries For Fourth Annual Young Farmer Sustainability Award
    3. Beekeepers, Growers Laud Bayer CropScience’s New Fluency Agent
    4. Bayer CropScience Charts Course For Cultivating Bee Health Solutions With Opening Of Clayton Bee Care Facility
    5. Bayer CropScience Discusses Sustainable Innovations in Food Security at Washington, D.C. Summit
    6. Bayer CropScience Introduces Specticle plus Fertilizer
    7. Bayer CropScience Debuts Serenade Optimum to Help Growers Control Tough Diseases and Combat Resistance
    8. Bayer CropScience Supports 10th Anniversary of United Way Of The Greater Triangle’s Girls’ Leadership Development Initiative
    9. Bayer CropScience and the Florida Specialty Crop Foundation Join Together to Fight Citrus Greening
    10. Bayer CropScience Adds Three New HBK Seed Varieties for 2014
    11. Bayer CropScience Looks to the Future of Farming at 2013 Farm Progress Show
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/30/2015)... ... July 30, 2015 , ... ... Francois Vieillard as Sales & Marketing Director. , With more than 25 ... be responsible for reinforcing Tronics’ business development activities worldwide. He brings to the ...
    (Date:7/30/2015)... 30, 2015   Aratana Therapeutics, Inc . ... focused on the licensing, development and commercialization of ... that its strategic partner VetStem Biopharma, Inc. has ... of AT-016, an adipose-derived allogeneic stem cell product ... osteoarthritis pain in dogs. The double-blinded, ...
    (Date:7/30/2015)... ST. LOUIS, July 30, 2015 ... period in 2014) , Reported sales were $697 ... of 2014.  Sales grew organically by 8%, and changes ... Recent acquisitions increased sales by 1%. , By ... 8% in Applied and 11% in SAFC Commercial. ...
    (Date:7/29/2015)... Sanofi, a global and ... quarter of 2015. CEO Olivier Brandicourt ... in different businesses. Watch video interview ... Topics covered in the interview include:  ... Performance drivers - Diabetes ...
    Breaking Biology Technology:Tronics appoints Francois Vieillard as Sales and Marketing Director 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 2Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 3Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 4Aratana Therapeutics Announces Positive Pilot Field Study for AT-016 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 2Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 3Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 4Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 5Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 6Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 7Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 8Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 9Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 10Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 11Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 12Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 13Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 14Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 15Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 16Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 17Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 18Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 19Sigma-Aldrich (NASDAQ - SIAL) Reports Q2 2015 Sales Of $697 Million And Adjusted Diluted EPS Of $1.01 20
    ... BASKING RIDGE, N.J., July 20 Regado Biosciences, ... therapeutic aptamers with active control agents, today announced the expansion ... (Dr. John Eikelboom of Canada, Dr. Philippe Menasche of France ... bringing the current size of the MAB to twelve. ...
    ... , London, July 20 There has ... the pharmaceutical and biotechnology space. While the economic downturn and related ... the recent M&A mania, which has including four mega M&As in ... (Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO ) , , ...
    ... EDMONTON, July 17 /PRNewswire-FirstCall/ - BioMS Medical Corp. (TSX: MS), ... today announced financial and operational results for the three and ... III MAESTRO-01 trial has completed the last patient last visit, ... second half of this year. This is the first of ...
    Cached Biology Technology:Regado Biosciences Expands Medical Advisory Board 2Regado Biosciences Expands Medical Advisory Board 3Regado Biosciences Expands Medical Advisory Board 4Big Pharma to Big Biopharma: Frost & Sullivan Examines the Latest M&A Trends and Opportunities 2BioMS Medical announces second quarter 2009 results 2BioMS Medical announces second quarter 2009 results 3BioMS Medical announces second quarter 2009 results 4BioMS Medical announces second quarter 2009 results 5BioMS Medical announces second quarter 2009 results 6BioMS Medical announces second quarter 2009 results 7BioMS Medical announces second quarter 2009 results 8BioMS Medical announces second quarter 2009 results 9
    (Date:7/21/2015)... 2015 Passwords have proven futile for ... recent U.S. Office of Personnel Management breach. Biometric ... conundrum, but developers and end-users are concerned about ... dilemma, Biometrics-as-a-Service provider HYPR Corp. announced today the ... third party integration. A video ...
    (Date:7/9/2015)... , July 07, 2015 ... the addition of the "Biometrics for Banking; ... 2015-2020" report to their offering. ... contributor to this growth and the forecast is ... in revenue for companies involved in delivering biometric ...
    (Date:7/8/2015)... , July 8, 2015  Trovagene, Inc. ... molecular diagnostics, today announced the launch of a ... Company,s Precision Cancer Monitoring℠ (PCM) technology for predicting ... one or a combination of the novel immunotherapy ... (nivolumab), a PD-1 inhibitor. The 50-patient study will ...
    Breaking Biology News(10 mins):HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4
    ... in mice suggests a novel strategy for treating damaged ... approach potentially could improve cardiac function, minimize scar size, ... and avoid the risk of tissue rejection. In ... ONE , ( http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0030329 ) the researchers isolated and ...
    ... European Molecular Biology Organization (EMBO) and the Federation ... director of the Friedrich Miescher Institute for Biomedical ... the 2012 FEBS/EMBO Women in Science Award. Professor ... research on genome stability and epigenetics and her ...
    ... University of Illinois , USA have discovered a new species ... Toledo District in southern Belize. Dr Sam Heads and Dr ... journal ZooKeys , documenting the discovery and ... commemorates the Mopan people a Mayan group, native to ...
    Cached Biology News:Stem cell study in mice offers hope for treating heart attack patients 2Stem cell study in mice offers hope for treating heart attack patients 3Susan M. Gasser to receive the 2012 FEBS/EMBO Women in Science Award 2
    ... D-2000, except that it uses a deep-UV deuterium ... and comes with a shutter (controlled via a ... Deuterium Light Source produces a powerful, stable output ... the light source are available, providing a wavelength ...
    ... FLUOstar OPTIMA is a fully automated ... life science labs in academia and ... measurement principles: Fluorescence Intensity ... Time-Resolved Fluorescence including DELFIATM ...
    ... These handy dispensers save space ... wipers, hats, and other garb. ... storage bins for small parts ... manufacturing. Clear acrylic. Open-slot design ...
    ... The MSD Security ChemStation ... GC/MS software application for ... quantification, library searching and ... aspects of data security, ...
    Biology Products: